Cluster Headache clinical trials

Explore recruiting cluster headache clinical trials.

Recruiting cluster headache studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cluster Headache trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SUNCET: Low sodium oxybate Use for Nocturnal Cluster headache: safety, Efficacy and Tolerability of XYWAV - a Phase 2 Randomized, Double-Blind, Placebo-Controlled, bi-center Study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase 3 randomized, placebo-controlled, triple blind parallel-group study of candesartan in adults with episodic cluster headache (Episodic CandClus2)

Denmark, Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and safety of minidosing lysergic acid diethylamide (LSD) for chronic cluster headache: a randomized placebo-controlled study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

KETALGIA : Evaluation of the effectiveness of a ketamine infusion combined with magnesium sulfate in the treatment of chronic refractory cluster headache

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

(REGON) Repeated corticosteroid injections around the Greater Occipital Nerve (GON) as prophylactic treatment in chronic cluster headache

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

BASIC - Botulinum toxin type A blockade of the sphenopalatine ganglion in treatment-refractory chronic cluster headache

Norway, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cluster Headache trials by city

Cluster Headache in Toronto Cluster Headache in Vancouver Cluster Headache in Montreal Cluster Headache in Calgary Cluster Headache in Edmonton Cluster Headache in Ottawa Cluster Headache in Winnipeg Cluster Headache in Quebec City Cluster Headache in Hamilton Cluster Headache in Kitchener Cluster Headache in London Cluster Headache in Halifax Cluster Headache in New York Cluster Headache in Los Angeles Cluster Headache in Chicago Cluster Headache in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease